OTCMKTS:CPHRF

Cipher Pharmaceuticals News Headlines

$1.09
+0.03 (+2.83 %)
(As of 04/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.09
Now: $1.09
$1.09
50-Day Range
$0.69
MA: $0.88
$1.17
52-Week Range
$0.53
Now: $1.09
$1.17
Volume505 shs
Average Volume16,166 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Cipher Pharmaceuticals (OTCMKTS CPHRF) News Headlines Today

SourceHeadline
Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF) Sees Significant Decrease in Short InterestCipher Pharmaceuticals Inc. (OTCMKTS:CPHRF) Sees Significant Decrease in Short Interest
americanbankingnews.com - April 13 at 7:48 PM
Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF) Short Interest UpdateCipher Pharmaceuticals Inc. (OTCMKTS:CPHRF) Short Interest Update
americanbankingnews.com - March 27 at 1:42 PM
Colorado Governor Approves Cannabis Social Equity BillColorado Governor Approves Cannabis Social Equity Bill
benzinga.com - March 25 at 8:32 AM
Cipher Pharmaceuticals Announces Automatic Repurchase Plan Pursuant to its Normal Course Issuer BidCipher Pharmaceuticals Announces Automatic Repurchase Plan Pursuant to its Normal Course Issuer Bid
finance.yahoo.com - March 25 at 8:32 AM
Cipher Pharmaceuticals (OTCMKTS:CPHRF) Price Target Increased to $0.95 by Analysts at Stifel NicolausCipher Pharmaceuticals (OTCMKTS:CPHRF) Price Target Increased to $0.95 by Analysts at Stifel Nicolaus
americanbankingnews.com - March 22 at 12:24 PM
Cipher Pharmaceuticals, Inc. (CPHRF) CEO Craig Mull on Q4 2020 Results - Earnings Call TranscriptCipher Pharmaceuticals, Inc. (CPHRF) CEO Craig Mull on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - March 20 at 10:09 PM
What Wall Street expects from Cipher Pharmaceuticalss earningsWhat Wall Street expects from Cipher Pharmaceuticals's earnings
markets.businessinsider.com - March 18 at 8:25 AM
Cipher Pharmaceuticals Schedules Q4 2020 Earnings Release and Conference CallCipher Pharmaceuticals Schedules Q4 2020 Earnings Release and Conference Call
finance.yahoo.com - March 10 at 7:19 PM
Heres The Latest On Aurora Cannabis Ahead Of Todays Earnings ReportHere's The Latest On Aurora Cannabis Ahead Of Today's Earnings Report
benzinga.com - February 13 at 6:22 PM
Cipher Pharmaceuticals Enters into Co-Promotion Agreement with Verity Pharmaceuticals Inc.Cipher Pharmaceuticals Enters into Co-Promotion Agreement with Verity Pharmaceuticals Inc.
finance.yahoo.com - February 10 at 7:28 PM
Acne Drugs Market 2020 COVID-19 Impact Analysis, Size, Share, Growth, Trends, Challenges and Opportunities, Forecast To 2025Acne Drugs Market 2020 COVID-19 Impact Analysis, Size, Share, Growth, Trends, Challenges and Opportunities, Forecast To 2025
marketwatch.com - February 5 at 3:30 PM
Are Psychedelics The Secret For Coma Patients? Why This Doctor Thinks They Might BeAre Psychedelics The Secret For Coma Patients? Why This Doctor Thinks They Might Be
benzinga.com - February 2 at 8:54 PM
Whats Next For Cannabis Marketing?What's Next For Cannabis Marketing?
benzinga.com - January 27 at 7:41 PM
Blueberries Medical Scores CA$1M In Financing, Confirms Leadership ChangesBlueberries Medical Scores CA$1M In Financing, Confirms Leadership Changes
benzinga.com - January 21 at 4:54 PM
YouTube Star Scotty Sire And Collaborator Jay Boice Discuss New Startup Venture iCBDYouTube Star Scotty Sire And Collaborator Jay Boice Discuss New Startup Venture iCBD
benzinga.com - January 7 at 12:03 AM
News for Cipher Pharmaceuticals IncShsNews for Cipher Pharmaceuticals IncShs
markets.businessinsider.com - December 30 at 5:21 AM
BevCanna To Close Naturo Acquisition In January, Calls Deal A Perfect FitBevCanna To Close Naturo Acquisition In January, Calls Deal A 'Perfect Fit'
benzinga.com - December 19 at 8:11 AM
Fire & Flower Revenue Spikes 142% YoY On Heels Of Buying SpreeFire & Flower Revenue Spikes 142% YoY On Heels Of Buying Spree
benzinga.com - December 16 at 7:01 PM
Imperial College Of London To Study Illegal Psychedelic Compound In First-Ever Clinical TrialImperial College Of London To Study Illegal Psychedelic Compound In First-Ever Clinical Trial
benzinga.com - December 14 at 12:22 AM
Virtual Cannabis Dinner Pairings Offer An Alternative To Heavy Alcohol Consumption During The PandemicVirtual Cannabis Dinner Pairings Offer An Alternative To Heavy Alcohol Consumption During The Pandemic
benzinga.com - December 4 at 10:23 PM
Her Highness Enters Nevada Market Via Body And Mind PartnershipHer Highness Enters Nevada Market Via Body And Mind Partnership
benzinga.com - November 26 at 11:03 PM
Y Combinator Startup Meadow Debuts Fundraising Tool For Cannabis BusinessesY Combinator Startup Meadow Debuts Fundraising Tool For Cannabis Businesses
benzinga.com - November 20 at 8:16 PM
Rebranding Cannabis: A New, Celeb-Packed Talk Show You Need To Check OutRebranding Cannabis: A New, Celeb-Packed Talk Show You Need To Check Out
benzinga.com - November 19 at 6:38 PM
Johns Hopkins University To Research Cannabinoid Therapies Via New PartnershipJohns Hopkins University To Research Cannabinoid Therapies Via New Partnership
benzinga.com - November 15 at 6:12 PM
Intrinsic Capital Partners Raises $102M To Back Ancillary Cannabis CompaniesIntrinsic Capital Partners Raises $102M To Back Ancillary Cannabis Companies
benzinga.com - November 14 at 12:37 AM
Cipher Pharmaceuticals (CPHRF) CEO Craig Mull on Q3 2020 Results - Earnings Call TranscriptCipher Pharmaceuticals' (CPHRF) CEO Craig Mull on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 13 at 2:34 PM
Cipher Pharmaceuticals EPS beats by $0.02, beats on revenueCipher Pharmaceuticals EPS beats by $0.02, beats on revenue
seekingalpha.com - November 12 at 10:48 PM
Oregon Becomes First US State To Decriminalize Drug Possession, Begins Psilocybin ProgramOregon Becomes First US State To Decriminalize Drug Possession, Begins Psilocybin Program
benzinga.com - November 6 at 8:05 PM
Cipher Pharmaceuticals Schedules Q3 2020 Earnings Release and Conference CallCipher Pharmaceuticals Schedules Q3 2020 Earnings Release and Conference Call
finance.yahoo.com - November 3 at 6:39 PM
Missouris Medical Marijuana Ambitions Have BegunMissouri's Medical Marijuana Ambitions Have Begun
benzinga.com - October 28 at 1:33 PM
Harborside Expects Revenue to Exceed $18.5M In Q3Harborside Expects Revenue to Exceed $18.5M In Q3
benzinga.com - October 14 at 1:56 PM
Exclusive: Cannabis Real Estate SPAC Plans $182M In AcquisitionsExclusive: Cannabis Real Estate SPAC Plans $182M In Acquisitions
benzinga.com - October 8 at 9:19 AM
Cipher Pharmaceuticals EPS misses by $0.05, misses on revenueCipher Pharmaceuticals EPS misses by $0.05, misses on revenue
seekingalpha.com - August 12 at 5:53 PM
Cipher Pharmaceuticals Reports Second Quarter 2020 Financial ResultsCipher Pharmaceuticals Reports Second Quarter 2020 Financial Results
finance.yahoo.com - August 12 at 5:53 PM
Cipher Pharmaceuticals names new finance chiefCipher Pharmaceuticals names new finance chief
seekingalpha.com - July 2 at 11:43 PM
Cipher Pharmaceuticals Inc. (CPHRF) CEO Craig Mull on Q1 2020 Results - Earnings Call TranscriptCipher Pharmaceuticals Inc. (CPHRF) CEO Craig Mull on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 8 at 4:00 PM
Cipher Pharmaceuticals EPS beats by $0.05, beats on revenueCipher Pharmaceuticals EPS beats by $0.05, beats on revenue
seekingalpha.com - May 8 at 3:34 AM
Cipher Pharmaceuticals Schedules Q1 2020 Earnings Release and Conference CallCipher Pharmaceuticals Schedules Q1 2020 Earnings Release and Conference Call
finance.yahoo.com - April 27 at 10:25 PM
Cipher Pharmaceuticals Receives Positive Ruling on Binding Arbitration with Upsher-Smith LaboratoriesCipher Pharmaceuticals Receives Positive Ruling on Binding Arbitration with Upsher-Smith Laboratories
finance.yahoo.com - April 20 at 7:59 PM
What Is Cipher Pharmaceuticals's (TSE:CPH) P/E Ratio After Its Share Price Rocketed?What Is Cipher Pharmaceuticals's (TSE:CPH) P/E Ratio After Its Share Price Rocketed?
finance.yahoo.com - April 12 at 9:23 AM
Cipher Pharmaceuticals EPS beats by $0.06, beats on revenueCipher Pharmaceuticals EPS beats by $0.06, beats on revenue
seekingalpha.com - March 25 at 9:35 PM
One Thing To Remember About The Cipher Pharmaceuticals Inc. (TSE:CPH) Share PriceOne Thing To Remember About The Cipher Pharmaceuticals Inc. (TSE:CPH) Share Price
finance.yahoo.com - March 12 at 8:07 AM
Cipher Pharmaceuticals Provides Update on Absorica Brand Extension Program with Sun PharmaceuticalCipher Pharmaceuticals Provides Update on Absorica Brand Extension Program with Sun Pharmaceutical
finance.yahoo.com - February 6 at 6:09 PM
Cipher Pharma receives termination notice from Bausch HealthCipher Pharma receives termination notice from Bausch Health
seekingalpha.com - January 21 at 1:57 PM
Some Cipher Pharmaceuticals (TSE:CPH) Shareholders Have Taken A Painful 93% Share Price DropSome Cipher Pharmaceuticals (TSE:CPH) Shareholders Have Taken A Painful 93% Share Price Drop
finance.yahoo.com - January 12 at 9:51 AM
Cipher Pharmaceuticals Inc. (CPHRF) CEO Craig Mull on Q3 2019 Results - Earnings Call TranscriptCipher Pharmaceuticals Inc. (CPHRF) CEO Craig Mull on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 10 at 8:01 AM
Cipher Pharmaceuticals Reports Third Quarter 2019 Financial ResultsCipher Pharmaceuticals Reports Third Quarter 2019 Financial Results
finance.yahoo.com - November 7 at 7:11 AM
Notice of Cipher Pharmaceuticals Q3 2019 Conference CallNotice of Cipher Pharmaceuticals Q3 2019 Conference Call
finance.yahoo.com - October 24 at 5:35 PM
Health Canada OKs Cipher Pharmas Trulance for IBS-CHealth Canada OKs Cipher Pharma's Trulance for IBS-C
seekingalpha.com - October 18 at 9:06 AM
What Percentage Of Cipher Pharmaceuticals Inc. (TSE:CPH) Shares Do Insiders Own?What Percentage Of Cipher Pharmaceuticals Inc. (TSE:CPH) Shares Do Insiders Own?
finance.yahoo.com - October 8 at 8:46 AM
This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.